TÜRK GERÇEKER B, TAŞKIN B, CAN C, GÜNERİ P, ÖZTÜRK G, AYTİMUR D, ÜNAL İ, APAYDIN F, ÇANKAYA H, SEZER B, DERELİ T

Oral liken planuslu olguların demografik ve klinik özellikleri

Amaç: Oral liken planus (OLP) retiküler, eritematöz-atrofik, eroziv lezyonlar ile karakterize, kronik inflamatuvar bir hastalıktır. Bu çalışmada oral liken planus tanısı alan olguların demografik ve klinik özelliklerinin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Bu amaçla çalışmaya Kasım 2006-Haziran 2008 tarihleri arasında polikliniğimize ve “Yüz ve Ağız İçi Lezyonları Konseyi”ne başvuran OLP tanısı almış 48 olgu dahil edildi. Lezyonların klinik özellikleri (retiküler, eroziv, eritematöz-atrofik, mikst tip) ve yerleşimi, hastaların demografik özellikleri, hastalık süresi, hastalığı tetikleyebilecek ilaç alımı, sigara kullanımı, diyabetes mellitus varlığı, hepatit belirteçleri, oral kandidiyazis, protez ve amalgam dolgu varlığı ile malign transformasyon değerlendirildi. Bulgular: Kırk sekiz hastanın 34’ü kadın (%70.8), 14’ü erkek (%29.2) idi. Yaş ortalamaları 55.4±12.5, mediyan hastalık süresi 12 ay idi. Olguların 26’sında (%54.2) retiküler ve 22’sinde (%45.8) retiküler, eritematöz-atrofik ve eroziv alanların birlikte görüldüğü mikst tipte lezyonlar izlendi. Mikst tipteki lezyonlar 60 yaş ve üzerinde daha sık gözlendi (p

Demographic and clinical features of patients with oral lichen planus

Aim: Oral lichen planus is a chronic, inflammatory disease which is characterized by reticular, erythematous-atrophic, and erosive lesions. The aim of this study was to investigate the demographic and clinical features of oral lichen planus patients. Materials and Methods: A total of 48 patients admitted to the outpatient clinic and “Face and Oral Mucosa Council” between November 2006 and June 2008 who were diagnosed with oral lichen planus were included into this study. The clinical features (reticular, erosive, erythematous-atrophic, mixed type) and localization of the lesions, demographic features of the patients, duration of the disease, possible triggering drug intake, smoking, presence of diabetes mellitus, hepatitis markers, oral candidiasis, prosthesis and amalgam restoration, and malignant transformation were evaluated.Results: Of the 48 patients, 34 (70.8%) were female, 14 (29.2%) were male. The mean age was 55.4±12.5 years, and the median duration of the disease was 12 months. Reticular lesions were observed in 26 patients (54.2%) and mixed lesions involving reticular, erythematous-atrophic and erosive and areas were observed in 22 patients (45.8%). Erosive lesions were more frequently observed in patients 60 years of age and over, and were associated with a possible triggering medication (p<0.05). Conclusion: It is indicated that mixed type lesions together with erosive areas are frequently observed in patients 60 years of age and over and by this study, it is also emphasized that drug usage should be checked in such cases.

PDF

___

1. Eisen D, Carrozzo M, Bagan Sebastian J-V, Thongprasom K. Oral lichen planus: Clinic features and management. Oral Dis 2005;11(6): 338-49.
2. Ingafou M, Leao JC, Porter SR, Scully C. Oral lichen planus: A retrospective study of 690 British patients. Oral Dis 2006;12(5):463-68.
3. Xue J-L, Fan MW, Wang S-Z, Chen X-M, Li Y, Wang L. A clinical study of 674 patients with oral lichen planus in China. J Oral Pathol Med 2005;34(8):467-72.
4. Anuradha C, Reddy BV, Nandan SR, Kumar SR. Oral lichen planus. A review. N Y State Dent J 2008;74(4):66-8.
5. Cebeci İ, Gülşahi A, Kamburoğlu K ve ark. Türk hastalarda oral liken planus: Prevalans, klinik ve histopatolojik özellikler. Turkiye Klinikleri J Med Sci 2009;29(5):1071-5.
6. Lundstrom IMC. Allergy and corrosion of dental materials in patients with oral lichen planus. Int J Oral Surg 1984;13(1):16-24.
7. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: A study of 723 patients. J Am Acad Dermatol 2002; 46(2):207-14.
8. Wang Z, Yao H, Cui B, Ning G, Tang GY. Genetic linkage analysis of oral lichen planus in a Chinese family. Genet Mol Res 2011;10(3):1427-33.
9. Petti S, Rabiei M, De Luca M, Scully C. The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology 2011;99(2):168-78.
10. Lodi G, Giuliani M, Majorana A, Sardella A, Bez C, Demarosi F, Carrassi A. Lichen planus and hepatitis C virus: A multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 2004;151(6):1172-81.
11. Bankaoğlu A, Gökdemir G, Altunay İK, Köşlü A. Kutanöz liken planuslu hastalarda oral ve dış genital mukoza tutulumu. TÜRKDERM 2003;37(2):100-3.
12. Manolache L, Seceleanu-Petrescu D, Benea V. Lichen planus patients and stressful events. J Eur Acad Dermatol Venereol 2008; 22(4):437-41.
13. Girardi C, Luz C, Cherubini K, Figueiredo MA, Nunes ML, Salum FG. Salivary cortisol and dehydroepiandrosterone (DHEA) levels, psychological factors in patients with oral lichen planus. Arch Oral Biol 2011;56(9):864-8.
14. Laeijendecker R, Dekker SK, Burger PM, Mulder PG, Van Joost T, Neumann MH. Oral lichen planus and allergy to dental amalgam restorations. Arch Dermatol 2004 ;140(12):1434-8.
15. Koch P, Bahmer FA. Oral lesions and symptoms related to metals used in dental restorations: A clinical, allergological, and histologic study. J Am Acad Dermatol 1999;41(3):422-30.
16. Gorsky M, Epstein JB, Hasson-Kanfi H, Kaufman E. Smoking habits among patients diagnosed with oral lichen planus. Tob Induc Dis 2004 15;2(2):103-8.
17. Nagao Y, Myoken Y, Katayama K, Tanaka J, Yoshizawa H, Sata M. Epidemiological survey of oral lichen planus among HCV- infected inhabitants in a town in Hiroshima Prefecture in Japan from 2000 to 2003. Oncol Rep 2007;18(5):1177-81.
18. Birkenfeld S, Dreiher J, Weitzman D, Cohen AD. A study on the association with hepatitis B and hepatitis C in 1557 patients with lichen planus. J Eur Acad Dermatol Venereol 2011;25(4):436-40.
19. Dogan B. Dermatological manifestations in hepatitis B surface antigen carriers in the eastern region of Turkey. J Eur Acad Dermatol Venereol 2005;19(3):323-5.
20. Bombeccari GP, Guzzi G, Tettamanti M, et al. Oral lichen planus and malignant transformation: A longitudinal cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112(3):328-34.
21. Van der Meij EH, Schepman KP, Smeele LE, van der Wal JE, Bezemer PD, van der Waal I. A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88(3):307-10.
22. Potts AJC, Hamburger J, Scully C. The medication of patients with oral lichen planus and association of nonsteroidal anti- inflamatory drugs with erosive lesions. Oral Surg Oral Med Oral Pathol 1987;64(5): 541-3.
23. Scully C, Beyli M, Ferreiro MC, et al. Update on oral lichen planus: Etiopathogenesis and management. Crit Rev Oral Biol Med 1998;9(1):86-122.
24. Hamburger J, Potts AJ. Non-steroidal anti-inflammatory drugs and oral lichenoid reactions. Br Med J 1983;287(6401):1258.